Correspondence 0001493152-25-005084 from Calidi Biotherapeutics, Inc. (CLDI)

Calidi Biotherapeutics, Inc.
Date: Feb. 6, 2025 · CIK: 0001855485 · Accession: 0001493152-25-005084

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-284229

Date

Feb. 6, 2025

Author

Chief

Form

CORRESP

Company

Calidi Biotherapeutics, Inc.

Letter

Calidi Biotherapeutics, Inc.

Executive Drive, Suite 200

San Diego, CA 92121

(858) 794-9600

February 5, 2025

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

F Street N.E.

Washington, D.C. 20549

Re: Calidi Biotherapeutics, Inc.

Registration Statement on Form S-3

File No. 333-284229

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 5:00 p.m., Eastern Time on Friday, February 7, 2025, or as soon thereafter as practicable.

Please contact Jay K. Yamamoto, Esq. of Sichenzia Ross Ference Carmel LLP at (646) 810-0604, as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter.

Very
truly yours,
CALIDI
BIOTHERAPEUTICS, INC.

Show Raw Text

CORRESP
1
filename1.htm

Calidi
Biotherapeutics, Inc.

4475
Executive Drive, Suite 200

San
Diego, CA 92121

(858)
794-9600

February
5, 2025

VIA
EDGAR

Securities
and Exchange Commission

Division
of Corporation Finance

100
F Street N.E.

Washington,
D.C. 20549

    Re:
    Calidi Biotherapeutics, Inc.

    Registration
    Statement on Form S-3

    File
    No. 333-284229

Ladies
and Gentlemen:

Pursuant
to Rule 461 promulgated under the Securities Act, the undersigned respectfully requests that the effective date for the Registration
Statement referred to above be accelerated so that it will be declared effective at 5:00 p.m., Eastern Time on Friday, February 7, 2025,
or as soon thereafter as practicable.

Please
contact Jay K. Yamamoto, Esq. of Sichenzia Ross Ference Carmel LLP at (646) 810-0604, as soon as the Registration Statement has been
declared effective, or if you have any other questions or concerns regarding this matter.

    Very
    truly yours,

    CALIDI
    BIOTHERAPEUTICS, INC.

    By:

    /s/
    Andrew Jackson

    Andrew
    Jackson

    Chief
    Financial Officer

SecProbe.io